Cargando…
AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review
Disabling limb spasticity can result from stroke, traumatic brain injury or other disorders causing upper motor neuron lesions such as multiple sclerosis. Clinical studies have shown that abobotulinumtoxinA (AboBoNT-A) therapy reduces upper and lower limb spasticity in adults. However, physicians ma...
Autores principales: | Schnitzler, Alexis, Dince, Clément, Freitag, Andreas, Iheanacho, Ike, Fahrbach, Kyle, Lavoie, Louis, Loze, Jean-Yves, Forestier, Anne, Gasq, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698883/ https://www.ncbi.nlm.nih.gov/pubmed/36355984 http://dx.doi.org/10.3390/toxins14110734 |
Ejemplares similares
-
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017) -
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Adult Upper Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2015) -
Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020) -
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Lower Limb Spasticity
por: Dashtipour, Khashayar, et al.
Publicado: (2016) -
Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension
por: Gracies, Jean-Michel, et al.
Publicado: (2017)